|
Volumn 24, Issue 3, 2000, Pages 201-202
|
Trials and tribulations
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD CLOTTING FACTOR 9 COMPLEX;
VIRUS VECTOR;
CLINICAL PROTOCOL;
DOSE RESPONSE;
EDITORIAL;
GENE THERAPY;
HEMOPHILIA B;
HUMAN;
INFORMED CONSENT;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETICS AND REPRODUCTION;
CLINICAL TRIALS;
CLINICAL TRIALS, PHASE I;
GENE THERAPY;
GENETIC VECTORS;
HEMOPHILIA B;
HUMANS;
INFORMED CONSENT;
PATIENT SELECTION;
RESEARCH DESIGN;
SAFETY;
TREATMENT OUTCOME;
|
EID: 0034006951
PISSN: 10614036
EISSN: None
Source Type: Journal
DOI: 10.1038/73387 Document Type: Editorial |
Times cited : (3)
|
References (0)
|